Literature DB >> 2934411

Deficiency of the adhesive protein complex lymphocyte function antigen 1, complement receptor type 3, glycoprotein p150,95 in a girl with recurrent bacterial infections. Effects on phagocytic cells and lymphocyte functions.

A Fischer, R Seger, A Durandy, B Grospierre, J L Virelizier, F Le Deist, C Griscelli, E Fischer, M Kazatchkine, M C Bohler.   

Abstract

A patient presenting delayed umbilical cord detachment, severe recurrent bacterial infections, and inability to form pus exhibited a profound defect in the expression of alpha- and beta-chains of the receptor for the C3bi fragment of C3 (CR3), lymphocyte function antigen 1 (LFA-1) molecule, and the p150,95 molecule found on neutrophils, monocytes, and lymphocyte membranes. This was shown by immunofluorescence studies using specific monoclonal antibodies, rosette formation with C3bi-coated erythrocytes, and immunoprecipitation for the LFA-1 complex. These membrane defects were responsible for abnormal phagocytic cell functions including adherence to nylon wool, cell movement, phagocytosis, and opsonized particle-induced oxidative response and for defective natural killer cell activity. In addition, lymphocyte function deficiencies previously unobserved in this disease were found. Cytolytic T lymphocyte activity was profoundly reduced; alpha- and gamma-interferon production were impaired. Finally, there was no antibody production to vaccinal antigens whereas the antibody responses to polysaccharides and to cytomegalovirus were found to be normal. The cytotoxic T cell deficiency could be expected from previous blocking experiments of this function with monoclonal antibodies to LFA-1 and is probably related to an extremely severe deficiency in LFA-1 expression in this patient. Anomalies in interferon and in antibody production suggest additional role(s) of the LFA-1 complex in monocyte/T lymphocyte/B lymphocyte cell interactions that have not yet been envisaged.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2934411      PMCID: PMC424386          DOI: 10.1172/JCI112251

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies.

Authors:  S D Wright; P E Rao; W C Van Voorhis; L S Craigmyle; K Iida; M A Talle; E F Westberg; G Goldstein; S C Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

2.  Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.

Authors:  F Sanchez-Madrid; A M Krensky; C F Ware; E Robbins; J L Strominger; S J Burakoff; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

3.  Modulation of human granulocyte and monocyte chemiluminescence responses: evidence for distinct free radical generating systems.

Authors:  A T Nguyen; R Golub; M N Feuillet-Fieux; B Descamps-Latscha
Journal:  J Clin Lab Immunol       Date:  1983-09

4.  Human lymphocyte function associated antigen-1 (LFA-1): identification of multiple antigenic epitopes and their relationship to CTL-mediated cytotoxicity.

Authors:  C F Ware; F Sanchez-Madrid; A M Krensky; S J Burakoff; J L Strominger; T A Springer
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

5.  Bone-marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis, and oxidative response during opsonised particle phagocytosis.

Authors:  A Fischer; P H Trung; B Descamps-Latscha; B Lisowska-Grospierre; I Gerota; N Perez; C Scheinmetzler; A Durandy; J L Virelizier; C Griscelli
Journal:  Lancet       Date:  1983-08-27       Impact factor: 79.321

6.  Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes.

Authors:  S D Wright; S C Silverstein
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

7.  Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.

Authors:  G D Ross; S L Newman; J D Lambris; J E Devery-Pocius; J A Cain; P J Lachmann
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

8.  Fibronectin and serum amyloid P component stimulate C3b- and C3bi-mediated phagocytosis in cultured human monocytes.

Authors:  S D Wright; L S Craigmyle; S C Silverstein
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

9.  Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.

Authors:  D I Beller; T A Springer; R D Schreiber
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule.

Authors:  F Sanchez-Madrid; J A Nagy; E Robbins; P Simon; T A Springer
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  14 in total

1.  LFA-1-dependent OKT3-driven T cell clusters in common variable immunodeficiency.

Authors:  W Rudnicka; N English; J Farrant; M E North; A E Bryant; A J Edwards; A Stackpoole; A D Webster; B M Balfour
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

2.  Absence of complement receptor type 3 and lymphocyte function antigen 1 causing deficient phagocyte and lymphocyte functions.

Authors:  M M Manzionna; R A Seger; V Wahn; R M Zinkernagel; A Böcker; W H Hitzig
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

3.  Defective neutrophil and lymphocyte function in leucocyte adhesion deficiency.

Authors:  Y L Lau; L C Low; B M Jones; J W Lawton
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

4.  Effects of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) on the expression of LFA-1 in the moderate phenotype of leukocyte adhesion deficiency (LAD).

Authors:  M T Dimanche-Boitrel; F Le Deist; A Quillet; A Fischer; C Griscelli; B Lisowska-Grospierre
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

5.  A study of 25 patients with chronic granulomatous disease: a new classification by correlating respiratory burst, cytochrome b, and flavoprotein.

Authors:  M C Bohler; R A Seger; R Mouy; E Vilmer; A Fischer; C Griscelli
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

6.  Effect of Kupffer cell phagocytosis of erythrocytes and erythrocyte ghosts on susceptibility to endotoxemia and bacteremia.

Authors:  D J Loegering; L M Commins; F L Minnear; L A Gary; L A Hill
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  LFA-1 immunodeficiency disease. Definition of the genetic defect and chromosomal mapping of alpha and beta subunits of the lymphocyte function-associated antigen 1 (LFA-1) by complementation in hybrid cells.

Authors:  S D Marlin; C C Morton; D C Anderson; T A Springer
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

8.  Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/alpha 4 beta 1 integrin interactions.

Authors:  V G Sasseville; W Newman; S J Brodie; P Hesterberg; D Pauley; D J Ringler
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

9.  Association of an abnormality of neutrophil chemotaxis in human periodontal disease with a cell surface protein.

Authors:  T E Van Dyke; C Wilson-Burrows; S Offenbacher; P Henson
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

10.  Comparison of blocking effects of monoclonal antibodies anti-MO1-alpha and anti-LFA1-alpha on human neutrophil functions.

Authors:  T Pham Huu; S Chollet-Martin; A Perianin; C Marquetty; P Sourbier; C Babin-Chevaye; D Olive; M A Gougerot-Pocidalo; P Debre; J Hakim
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.